244 related articles for article (PubMed ID: 21182420)
1. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
de Pace RC; Liu X; Sun M; Nie S; Zhang J; Cai Q; Gao W; Pan X; Fan Z; Wang S
J Liposome Res; 2013 Sep; 23(3):187-96. PubMed ID: 23600473
[TBL] [Abstract][Full Text] [Related]
3. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
Stuart EC; Scandlyn MJ; Rosengren RJ
Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
[TBL] [Abstract][Full Text] [Related]
4. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
Sanna V; Pintus G; Roggio AM; Punzoni S; Posadino AM; Arca A; Marceddu S; Bandiera P; Uzzau S; Sechi M
J Med Chem; 2011 Mar; 54(5):1321-32. PubMed ID: 21306166
[TBL] [Abstract][Full Text] [Related]
5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
6. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Siddiqui IA; Adhami VM; Bharali DJ; Hafeez BB; Asim M; Khwaja SI; Ahmad N; Cui H; Mousa SA; Mukhtar H
Cancer Res; 2009 Mar; 69(5):1712-6. PubMed ID: 19223530
[TBL] [Abstract][Full Text] [Related]
7. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
8. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
[TBL] [Abstract][Full Text] [Related]
9. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
10. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.
Yu HN; Shen SR; Xiong YK
J Zhejiang Univ Sci B; 2005 Feb; 6(2):125-31. PubMed ID: 15633248
[TBL] [Abstract][Full Text] [Related]
12. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
Sadava D; Whitlock E; Kane SE
Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
[TBL] [Abstract][Full Text] [Related]
13. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
[TBL] [Abstract][Full Text] [Related]
14. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles.
Tyagi N; De R; Begun J; Popat A
Int J Pharm; 2017 Feb; 518(1-2):220-227. PubMed ID: 27988378
[TBL] [Abstract][Full Text] [Related]
15. Nanochemoprevention by bioactive food components: a perspective.
Siddiqui IA; Mukhtar H
Pharm Res; 2010 Jun; 27(6):1054-60. PubMed ID: 20221894
[TBL] [Abstract][Full Text] [Related]
16. Lipid/particle assemblies based on maltodextrin-gum arabic core as bio-carriers.
Gomes JF; Rocha S; do Carmo Pereira M; Peres I; Moreno S; Toca-Herrera J; Coelho MA
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):449-55. PubMed ID: 20060275
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of oral cancer by green tea.
Hsu SD; Singh BB; Lewis JB; Borke JL; Dickinson DP; Drake L; Caughman GB; Schuster GS
Gen Dent; 2002; 50(2):140-6. PubMed ID: 12004708
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
Xu Q; Yang CH; Liu Q; Jin XF; Xu XT; Tong JL; Xiao SD; Ran ZH
J Dig Dis; 2011 Jun; 12(3):181-7. PubMed ID: 21615871
[TBL] [Abstract][Full Text] [Related]
19. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
